FilingReader Intelligence

Haisco Pharmaceutical plans 965 million yuan share issuance

August 13, 2025 at 08:22 AM UTCBy FilingReader AI

Haisco Pharmaceutical Group plans to issue up to 70 million A shares in a non-public offering to raise up to 1.37 billion yuan.

The proceeds will fund new drug research and development projects (965 million yuan) and supplement working capital (400 million yuan). The issuance requires approval from the Shenzhen Stock Exchange and China Securities Regulatory Commission.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Haisco Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →